Like SDH, FH is a tumor suppressor, and loss of heterozygosity will predispose FH mutant carriers to develop disorders including renal cell cancer, cutaneous and uterine leiomyomas, and encephalopathies [139]. The gene discussed is FH; the disease is Uterine leiomyoma.